Search Results for: diy gene therapy

Claim of Liz Parrish DIY gene therapy linked to unlicensed stem cell clinic

Elizabeth-Parrish

In a strange, but fascinating tale recounted by Antonio Regalado in an article over at MIT Tech Review, we hear the first claim of a do-it-yourself (DIY) gene therapy involving a firm called BioViva and its leader Liz Parrish. Liz Parrish and BioViva The owner of a small biotech called BioViva, Liz Parrish, reportedly traveled […]

Claim of Liz Parrish DIY gene therapy linked to unlicensed stem cell clinic Read More »

Is Liz Parrish the world’s most genetically modified person? Why it might not be such a good thing

Liz Parrish, BioViva

Some recent claims had me wondering whether Liz Parrish is the world’s most genetically modified person. She and her firm BioViva are making that claim. It’s an important question but maybe not for the reason many of us first might think. This is not really about one person. Instead, this is a weighty question because

Is Liz Parrish the world’s most genetically modified person? Why it might not be such a good thing Read More »

Grading my 21 stem cell & regenerative medicine predictions for 2021

stem-cell-crystal-ball-300x3001

The world of stem cell research and regenerative medicine is unpredictable but it’s fun to be a part of it and try to do predictions. Each year in late December or early January I make prognostications for the coming year for stem cell research and regenerative medicine. I made 21 such predictions for the current

Grading my 21 stem cell & regenerative medicine predictions for 2021 Read More »

21 Stem Cell Research & Regenerative Medicine 2021 Predictions

stem-cell-crystal-ball-300x3001

In any given field of biomedical science like stem cell research and regenerative medicine, it’s very useful if you can accurately predict the future. It seems, though, that predictions are far more difficult within the more exciting and rapidly-changing fields. The field of stem cells and regenerative medicine fits that bill. Past stem cell research

21 Stem Cell Research & Regenerative Medicine 2021 Predictions Read More »

Perspectives on Biohackers and DIY CRISPR

biohackers series sm

How should we view biohackers and their DIY use of CRISPR outside of the traditional industry or academic lab environment? Introduction to “Biohackers” and DIY CRISPR Who are biohackers exactly? They are people who “hack” their own biology by transforming their bodies through the insertion of technology or modification of their DNA. More rarely, biohackers

Perspectives on Biohackers and DIY CRISPR Read More »

Tick Tock Genetic Clock: How soon until first DIY CRISPR of self?

I just did a blog post today on the striking story of someone doing DIY CRISPR gene therapy on themselves. A question came to mind. How long until someone does a DIY attempt to CRISPR themselves? In the DIY gene therapy story, the person was injected with so-called “gain-of-function” viruses to try to reap health

Tick Tock Genetic Clock: How soon until first DIY CRISPR of self? Read More »

DIY human ‘upgrades’ via biohacking

biohacking

Heritable human genetic modification has been the topic of the year so far, but another trend is edgy and interesting: non-heritable, but cutting edge forms of human modification that in some ways fall into the class of biohacking. Biohackers are into do-it-yourself (DIY) forms of biology including self-modification. Sure, people have been modifying themselves for

DIY human ‘upgrades’ via biohacking Read More »

George Church on Germline Human Genetic Modification

George-Church

I recently interviewed leading genomics scientist George Church on the ways that trends in genomics are changing our world. We also discussed the possibility of heritable human genetic modification. These days we more often call this “CRISPR babies.” His answers suggest that genomics and gene editing are poised to radically change our world. They could literally

George Church on Germline Human Genetic Modification Read More »

Weekly reads: Vertex, stem cells for MS, Athersys, 900-day paper review at Nature

“While still early, these results support the continued progression of our VX-880 clinical studies, as well as future studies using our encapsulated islet cells, which hold the potential to be used without the need for immunosuppression,” said Bastiano Sanna, Ph.D., executive vice president and chief of cell and genetic therapies at Vertex.

Vertex Pharmaceuticals has a lot going for it right now on the cell therapy front. For instance, they have the strongest type 1 diabetes cell therapy pipeline after some recent acquisitions. Still it’s not a simple matter to succeed in the cell therapy space even with one therapy for one targeted disease. Trials are tough

Weekly reads: Vertex, stem cells for MS, Athersys, 900-day paper review at Nature Read More »